⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Incidence and Prevalence of Myasthenia Gravis: Analysis of a US Commercial Insurance Claims Database (P4-11.016)

Paola Mina‐Osorio Joel Arackal Jingyu Wang Jennifer Schwinn Brett Venker

View Full Paper

Ask AI

Bookmark

Share

Abstract

To estimate the prevalence and incidence of myasthenia gravis (MG) in the United States (US) and describe patient demographics.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mina‐Osorio et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db6435876780c0 https://doi.org/10.1212/wnl.0000000000204748

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Epidemiology of myasthenia gravis in the United States2024 · 40 citations
2Analysis of Serious Infections and Malignancy Risk in Myasthenia Gravis: A US Claims Database Study (P10-11.007)2024 · 3 citations
3Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data2024 · 12 citations
4Comorbidity Burden and Steroid Use in Generalized Myasthenia Gravis: A Retrospective Analysis of Medicare Fee-for-service Claims (P4-11.015)2024 · 1 citations
5Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population SurveyOriginal Research · 1991 · 136 citations